PHA welcomes the opportunity to partner with other groups that are working to advance the diagnosis and treatment of pulmonary hypertension. For more information about partnering with PHA, contact Medical@PHAssociation.org.
The AARC is the premier organization for respiratory care providers, providing many opportunites for education and professional growth.
Through a partnership with with the Keystone Symposium on Pulmonary Vascular Disease and Right Ventricular Dysfunction: Current Concepts and Future Therapies, a four-day conference held in Monterey, Calif. September 10-15, 2012, conference sessions are available for viewing on PHA Online University.
Through a partnership with University of California, San Francisco, PHA is able to present the recordings of the presentations from the Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference in 2011 and 2012. In this annual symposium, UCSF brings together international experts to explore the current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric, and adult pulmonary vascular diseases.
The Pulmonary Hypertension Research Group at the Laval University Institute of Cardiology and Pulmonology in Quebec is a group of clinicians and researchers working to reveal the pathogenesis of PH, identify the mechanisms of the disease, and develop new therapeutic approaches in order to improve the care of patients with PH.